AZUSA, CA--(Marketwire - February 05, 2008) - Viral Genetics, Inc. (PINKSHEETS: VRAL), a biotechnology company, is pleased to announce that it has made additional progress in its research as a result of the recent acquisition of technology developed by Dr. Karen Newell at the University of Colorado, Colorado Springs (for complete details of the licensing transaction see the Company’s press release and Form 8-K of December 20, 2007).
